AASLD case-based session highlights advances in cirrhosis management

AASLD case-based session highlights advances in cirrhosis management

The management of cirrhosis has evolved at a rapid pace in recent years. During a case-based AASLD symposium on the final day of DDW® 2018, three experts reviewed the most recent developments in diuretic resistant/refractory ascites, recurrent/refractory hepatic encephalopathy and recurrent/refractory variceal bleeding. The panel was co-moderated by Catherine Frenette, MD, FAST, AGAF.

Is an HCV cure rate of 100 percent realistic?

Is an HCV cure rate of 100 percent realistic?

Although antiviral therapy has led to a cure rate of more than 90 percent of hepatitis C virus (HCV) cases, David E. Bernstein, MD, FAASLD, thinks more can be done to increase the cure rate. In this DDW Daily News video exclusive, Dr. Bernstein discusses several obstacles preventing patients’ access to curative therapies. He also addresses the benefits of HCV therapy and whether it’s possible to eradicate HCV and achieve 100 percent cure rate.